General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0PULZQ
ADC Name
YL201
Synonyms
YL 201; YL-201
   Click to Show/Hide
Organization
Mersana Therapeutics, Inc.;Suzhou Medilink Therapeutics Ltd.
Drug Status
Phase 1
Indication
In total 1 Indication(s)
Solid tumors [ICD11:2A00-2A0Z|2B50-2F9Z]
Phase 1
Antibody Name
Undisclosed
Antigen Name
CD276 antigen (CD276)
 Antigen Info 
Payload Name
Undisclosed
Linker Name
Undisclosed

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.